Erratum to "Prevalence of obesity/adiposity in Japanese psoriasis patients: Adiposity is correlated with the severity of psoriasis" [J. Dermatol. Sci. 54 (2009) 61-63] (DOI:10.1016/j.jdermsci.2008.11.011);Prevalence of obesity/adiposity in Japanese psoriasis patients: Adiposity is correlated with the severity of psoriasis

Journal of Dermatological Science

Volumn 54, Issue 1, 2009, Pages 61-63

  Takahashi, Hidetoshi ^a   Tsuji, Hitomi ^a   Takahashi, Ichiro ^a   Hashimoto, Yoshio ^a   Ishida Yamamoto, Akemi ^a   Iizuka, Hajime ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

Body mass index; Disease activity; Percent body fat; Psoriasis; Visceral adiposity

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; LEPTIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; BODY MASS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; JAPANESE; LETTER; MAJOR CLINICAL STUDY; MALE; OBESITY; PREVALENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PSORIASIS;

EID: 60749085882     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2009.04.003     Document Type: Erratum

References (10)

1. Gisondi P., Tessari G., Conti A., Piaserico S., Schianchi S., Peserico A., et al. Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study. Br J Dermatol 157 (2007) 68-73
2. Arican O., Aral M., and Sasmaz S. Serum levels of TNF-α, IFN-γ, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity. Med Inflamm 5 (2005) 273-279
3. Campfield L.A., Smith F.J., Guisez Y., Devos R., and Burn P. Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 269 (1995) 546-549
4. Matsuzaka Y. The metabolic syndrome and adipocytokines. FEBS Lett 580 (2006) 2917-2921
5. Hulthe J., Hulten L.M., and Fagerberg B. Low adipocyte-derived plasma protein adiponectin concentration is associated with metabolic syndrome and small dense low-density lipoprotein particles: atherosclerosis and insulin resistance study. Metabolism 52 (2003) 1612-1614
6. Maeda M., Shimomura I., Kishida K., Nishizawa H., Matsuda M., Nagaretani H., et al. Diet-induced insulin resistance in mice lacking adipocectin/ACRP30. Nat Med 8 (2002) 731-737
7. Takahashi H., Tsuji H., Takahashi I., Hashimoto Y., Ishida-Yamamoto A., and Iizuka H. Plasma adiponectin and leptin levels in Japanese psoriasis patients. Br J Dermatol 159 (2008) 1207-1208
8. Sommer D.M., Jenisch S., Suchan M., Christophers E., and Weichenthal M. Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis. Arch Dermatol Res 298 (2006) 321-328
9. Sano S., Chan K.S., Carbajal S., Clifford J., Peavey M., Kiguchi K., et al. Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model. Nat Med 11 (2005) 43-49
10. Nishida M., Funahashi T., and Shimomura I. Pathophysiological significance of adiponectin. Med Mol Morphol 40 (2007) 55-67